DISEASE NAME:
Acute Flaccid Paralysis (AFP)
CATEGORY:
Vaccine Preventable
Acute Flaccid Paralysis (AFP)
Acute flaccid paralysis (AFP) is a complex clinical syndrome with a broad array of potential aetiologies characterised by rapid onset of weakness, including weakness of respiratory and swallowing, progressing to maximum severity within several days to weeks.
AFP reporting and investigation in children less than 15 years of age is used as an indicator of quality syndromic surveillance that is used to ensure that if a case of AFP caused by acute poliomyelitis were to occur that it would be rapidly identified.
If AFP occurs in an individual 15 years of age or older who has recently arrived from a polio endemic country, similar investigations may be indicated to outrule polio virus.
Investigation and reporting of Acute Flaccid Paralysis (AFP) in children <15 years of age
01, Mar 2023
584.13 KB
Guidance
Acute flaccid paralysis (AFP) reporting [poster]
24, Oct 2023
509.66 KB
Investigation and reporting of Acute Flaccid Paralysis (AFP) in children <15 years of age
01, Mar 2023
584.13 KB
Acute Flaccid Paralysis (AFP) Surveillance: What is it and why are we doing it?
28, Jun 2019
113.97 KB
Causes of Acute Flaccid Paralysis (AFP) Worldwide
28, Jun 2019
198.99 KB